Covaxin Generated Excellent Safety Data, Says Bharat Biotech

Covaxin Generated Excellent Safety Data, Says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with robust immune responses to multiple viral proteins that persist.

Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses, the Hyderabad-based company said in a statement.

"The evaluation of Covaxin has resulted in several unique product characteristics including long term persistence of immune responses to multiple viral proteins, as opposed to only the spike protein, and has demonstrated broad spectrum neutralising capability with heterologous SARS-CoV2 strains, thus potentially reducing or eliminating escape mutants," it said.

"It has also shown to generate memory T cell responses, for its multiple epitopes, indicating longevity and a rapid antibody response to future infections. Its most critical characteristic is the demonstrated safety profile, which is significantly lower than several other vaccines with published data," it added.

DCGI has come under flak from various quarters for approving Covaxin even before the completion of Phase 3 trials. Critics wondered how the regulator could approve the vaccine in the absence of the data from Phase 3.

The DCGI's approval to Covaxin came a day after the Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) made the recommendation.

Bharat Biotech said it submitted all the data to the DCGI and CDSCO as per the regulatory guidelines.

The product development and clinical trial data thus far has generated 5 publications, which have been submitted to international peer reviewed journals, 4 of which have been accepted and will be published soon. The publication of Phase 2 trial data is undergoing the peer review process, the company said.

The DCGI stated that Bharat Biotech generated safety and immunogenicity data in various animal species. "All these data has been shared by the firm with CDSCO. Phase 1 and Phase 2 clinical trials were conducted in approx 800 subjects and the results have demonstrated that the vaccine is safe and provides a robust immune response. The Phase 3 efficacy trial was initiated in India in 25,800 volunteers and till date, 22,500 participants have been vaccinated across the country and the vaccine has been found to be safe as per the data available till date," the regulator said.

"The Subject Expert Committee (SEC) has reviewed the data on safety and immunogenicity of the vaccine and recommended for grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains. The clinical trial ongoing within the country by the firm will continue," it added.

India's indigenous Covid vaccine by Bharat Biotech has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

It is inactivated intramuscular vaccine that works by injecting the inactivated version of Sars-Cov-2, the virus which causes Covid-19, into the body to develop an immune response.

According to the vaccine maker, Covaxin has been evaluated in approximately 1000 subjects in Phase 1 and Phase 2 clinical trials, with promising safety and immunogenicity results, with acceptance in international peer reviewed scientific journals.

The Phase 3 human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India. This is India's first and only Phase 3 efficacy study for a Covid-19 vaccine, and the largest Phase 3 efficacy trial ever conducted for any vaccine in India.

This indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment facility, one of its kind in the world, said Bharat Biotech Chairman and Managing Director Dr Krishna Ella.

It was in June that Bharat Biotech had announced that it successfully developed Covaxin in collaboration with the ICMR and the NIV.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The Phase 1 trials began in July while Phase 2 trials started in September.

Sai Prasad, Executive Director, Bharat Biotech had told IANS in November that Covaxin was found to be safe without any major adverse events in the first two stages of the trials.

"We follow a well-designed vaccine development protocol, and ensure each stage of our vaccine development is driven with a sole goal to attain a strong immune response rate in our clinical trials. When we do a trial design, we take into account the attack rates, the disease type, the ability of us to detect the disease and then the recruitment timelines," the official had said when asked about the comparison with vaccines being developed by several companies around the world.

The company has already built capacities to manufacture 200 million doses of vaccine and plan to further enhance to 500 million doses.

It is investing about Rs 350-400 crore for the development of vaccine and the new manufacturing facilities, which includes investments for conducting the Phase 3 trials.

Subscribe to Trend in Google News! Subscribe
Expat doctors worked alongside Kuwaiti counterparts to revive Kuwaiti health sector: Dr Riyadh Khan
Expat doctors worked alongside Kuwaiti counterparts to revive Kuwaiti health sector: Dr Riyadh Khan
An extra meal and snacks twice a day was all it took to improve falling nutrition levels in this tribal district
An extra meal and snacks twice a day was all it took to improve falling nutrition levels in this tribal district
Nadal beats Mannarino in battle of left-handers to reach last eight
Nadal beats Mannarino in battle of left-handers to reach last eight
Loading Bars
Latest
Russia confirms over 63,200 COVID-19 daily cases
Azerbaijan prioritizes creation of food safety through local production
Azerbaijani Defense Ministry presents weekly review (VIDEO)
Expat doctors worked alongside Kuwaiti counterparts to revive Kuwaiti health sector: Dr Riyadh Khan
Iran reveals COVID-19 data for January 23
Weekly review of main events of Azerbaijani financial market
Weekly review of main events in Azerbaijan’s ICT sector
Iran discloses volume of electricity generated by Gilan Combined Cycle Power Plant
Weekly review of Azerbaijani precious metals market
Azerbaijan commissions new military facilities (PHOTO/VIDEO)
Tickets are available for two bus trips to Azerbaijan’s liberated Aghdam city
Tank and artillery shells found in Azerbaijan’s Samur-Absheron canal (PHOTO/VIDEO)
Bosphorus Strait temporarily closed in both directions
One person killed, two hurt in Budapest hospital fire -police
Intercity bus plunges into abyss in Turkey’s Istanbul city
An extra meal and snacks twice a day was all it took to improve falling nutrition levels in this tribal district
Almost all Kazakhstan remains in COVID-19 ‘red zone’
Nadal beats Mannarino in battle of left-handers to reach last eight
Azerbaijan holds training exercises in commando military unit (VIDEO)
Georgia reports 9,696 coronavirus cases, 5,408 recoveries, 28 deaths
Training session for reservists continues in Azerbaijan (VIDEO)
Iranian currency rates for January 23
Arab League delays annual summit as COVID-19 bites again
Turkey plans to hold next meeting within "3 + 3" format - Erdogan
New Zealand PM Jacinda Ardern cancels her wedding amid new Omicron restrictions
S.Korea says Iran to regain UN vote after delinquent dues paid with frozen funds
Electricity generation of Iran’s Bandar Abbas TPP surges
Uz-Kor Gas Chemical opens tender for purchase spare parts for analyzers and gas detectors
SCO to consider draft program proposed by Uzbekistan
Iran-Russia annual trade to increase to $10 b from $4 b
Kazakhstan confirms 14,012 new COVID-19 cases in 24 hr
French EU lawmaker Collard joins far-right presidential candidate Zemmour
Pfizer, Moderna boosters up to 90% effective against Omicron: CDC
Turkey’s Turkovac to be tested as booster for Pfizer-BioNTech jab
Guinea junta establishes council to lead transition to elections
Visit aims to rebuild trust with Lebanon: Kuwait foreign minister
UK records 76,807 new COVID cases, 297 deaths
EU Commissioner for Energy to visit Azerbaijan
Pfizer CEO sees annual COVID vaccine rather than frequent boosters
US Dept of State plans to begin evacuation of US embassy staff from Kiev on Jan 24
Blast hits western Afghan city of Herat, killing at least six
Georgia’s coal imports from Kazakhstan triple
Presidential administration of Georgia submits candidates for election commission to parliament
Remittances to Uzbekistan in 2021 totaled USD 8 bln
Iran seeks long-term, all-out ties with Turkey - Raeisi
Massive California wildfire triggers evacuations, closes highway
Italy's Berlusconi decides against running for president
Azerbaijan, Iran talk military cooperation
Azerbaijani chess player continues to lead in Tata Steel Masters tournament
Serviceman of Azerbaijan Army dies in non-combat conditions
Number of Turkish jobseekers in Uzbekistan revealed for 2021
UAE stops all private drone activities, light sports aircrafts
Airbus cancels $6bn contract with Qatar Airways
German conservatives elect right-winger Merz as new party leader
Non-hydro renewables overtake hydro for first time in Turkey
Record-breaking indicators in non-oil sector - what is secret to success of Azerbaijan's economic strategy?
Iran shares data on exports from Aras Free Trade Zone
Kazakhstan names damage caused to business as result of large-scale rallies
Georgia publishes COVID-19 data for January 22
Iran’s Bahar Azadi gold coin price dips
India now allows 6 people to register on one number for Covid vaccination
Azerbaijan shares data on number of vaccinated citizens
Azerbaijan confirms 1,614 more COVID-19 cases, 610 recoveries
Azerbaijan changes rules for quarantine control of Covid-19
India's Karnataka approves design & launch of nano-satellite by govt school students at Rs 1.9 Cr
‘One Modi cannot change a country, need more icons like him’: Himanta Biswa Sarma
Seizing of illegally stored weapons from citizens continues in Kazakhstan - interior minister
Azerbaijani border serviceman commits suicide in military hospital
Iran unveils details of agricultural export
Kazakh Armed Forces performing tasks to ensure public order in regions with “red” level of terrorist threat
Tokyo hits record 10,000 COVID cases, Japan over 50,000 for first time
Number of COVID-19 infections in Russia surpasses 11 mln since pandemic began
Kazakhstan developing measures to reform Samruk-Kazyna Fund's activities
PMO records surge in load/unload operations at Iranian ports
S&P predicts gas production growth in Azerbaijan through 2025
Turkmen medical enterprise discloses production data
Azerbaijan to hold auction for Ferrum Kapital CJSC's bonds
Kazakh president talks need to continue work to reveal all circumstances of recent riots
Kazakh oil and gas company to purchase helium via tender
Iran reveals COVID-19 data for January 22
Oil price spikes likely in 2022 amid inventory tightness midyear
7 killed, 16 injured in massive fire in central Mumbai high-rise
Oil demand to be robust in coming years despite net-zero strategies
India reports 3,37,704 new Covid cases, 488 deaths in 24 hours
Number of COVID-19 infections in Russia surpasses 11 mln since pandemic began
OPEC+ focus to switch away from propping up prices
Iran shares data on buy/sell operations at its Mercantile Exchange
Most people feel I-T exemption limit could be raised from Rs 2.5 lakh: India's KPMG
Turkmenistan’s Balkandokma complex doubles cotton yarn sales
Uzbekistan reveals data on agricultural, forestry and fisheries production
Tax benefits to increase disposable income likely in India's Union Budget
Uzbekistan approves procedure for rational use of land resources
S&P discloses inflation forecast for Azerbaijan through 2025
S&P Global Ratings announces forecast for Azerbaijan's budget surplus
Magnitude 6.2 earthquake strikes Unalaska, Alaska
NIOC agrees with Russian companies to develop Iran's oil, gas fields
SOCAR dismisses information about purchasing bitumen plant in Armenia
Kazakh company eyes to import leather products from Uzbekistan
S&P comments on possible swap line between Central Banks of Azerbaijan and Turkey
Oil production in Azerbaijan to moderately rebound - S&P
All news